Exactly. Very confusing to not lead off with the revenue generating product that is already FDA cleared, and is being manufactured by an ISO-13485 certified manufacturer and is being marketed by a very knowledgeable team at Verséa Ophthalmics. Very interesting.
However the video does make me think that the Parkinsons disease test must be generating a lot of interest from one or more Big Pharma companies. Since it is a Tear-based Point-of-Care quantitative Diagnostics test one would think it would play well in the EyeCare space.
Is it rock solid interest? Is it backed up by $$Millions in a down payment AND residual $ dollars to AXIM for each test?